Follow
Andrea Mastrangelo
Andrea Mastrangelo
Verified email at studio.unibo.it
Title
Cited by
Cited by
Year
Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes
C Quadalti, G Calandra-Buonaura, S Baiardi, A Mastrangelo, M Rossi, ...
npj Parkinson's Disease 7 (1), 93, 2021
722021
Plasma and CSF neurofilament light chain in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study
V Vacchiano, A Mastrangelo, C Zenesini, M Masullo, C Quadalti, P Avoni, ...
Frontiers in Aging Neuroscience 13, 753242, 2021
532021
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden
GM Bentivenga, A Mammana, S Baiardi, M Rossi, A Ticca, F Magliocchetti, ...
Acta Neuropathologica 147 (1), 18, 2024
202024
Elevated plasma p-tau181 levels unrelated to Alzheimer’s disease pathology in amyotrophic lateral sclerosis
V Vacchiano, A Mastrangelo, C Zenesini, S Baiardi, P Avoni, B Polischi, ...
Journal of Neurology, Neurosurgery & Psychiatry 94 (6), 428-435, 2023
142023
Evaluation of the impact of CSF prion RT-QuIC and amended criteria on the clinical diagnosis of Creutzfeldt-Jakob disease: a 10-year study in Italy
A Mastrangelo, A Mammana, S Baiardi, D Tiple, E Colaizzo, M Rossi, ...
Journal of Neurology, Neurosurgery & Psychiatry 94 (2), 121-129, 2023
122023
Diagnostic and prognostic performance of CSF α‐synuclein in prion disease in the context of rapidly progressive dementia
A Mastrangelo, S Baiardi, C Zenesini, A Poleggi, A Mammana, B Polischi, ...
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 13 (1 …, 2021
112021
Levels of plasma brain‐derived tau and p‐tau181 in Alzheimer's disease and rapidly progressive dementias
F Gonzalez‐Ortiz, TK Karikari, GM Bentivenga, S Baiardi, A Mammana, ...
Alzheimer's & Dementia 20 (1), 745-751, 2024
62024
High diagnostic performance of plasma and cerebrospinal fluid beta‐synuclein for sporadic Creutzfeldt–Jakob disease
S Abu‐Rumeileh, S Halbgebauer, GM Bentivenga, L Barba, S Baiardi, ...
Annals of Clinical and Translational Neurology 10 (10), 1904-1909, 2023
52023
Amyloid-Beta Co-Pathology Is a Major Determinant of the Elevated Plasma GFAP Values in Amyotrophic Lateral Sclerosis
A Mastrangelo, V Vacchiano, C Zenesini, E Ruggeri, S Baiardi, A Cherici, ...
International Journal of Molecular Sciences 24 (18), 13976, 2023
42023
Diagnostic and prognostic value of cerebrospinal fluid SNAP-25 and neurogranin in Creutzfeldt-Jakob disease in a clinical setting cohort of rapidly progressive dementias
GM Bentivenga, S Baiardi, A Mastrangelo, C Zenesini, A Mammana, ...
Alzheimer's Research & Therapy 15 (1), 150, 2023
42023
Prodynorphin and Proenkephalin in Cerebrospinal Fluid of Sporadic Creutzfeldt–Jakob Disease
S Abu-Rumeileh, P Barschke, P Oeckl, S Baiardi, A Mammana, ...
International journal of molecular sciences 23 (4), 2051, 2022
42022
Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt–Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia
GM Bentivenga, S Baiardi, A Mastrangelo, C Zenesini, A Mammana, ...
International Journal of Molecular Sciences 25 (10), 5106, 2024
2024
The genetic puzzle of a SOD1-patient with ocular ptosis and a motor neuron disease: a case report
V Vacchiano, F Palombo, D Ormanbekova, C Fiorini, A Fiorentino, ...
Frontiers in Genetics 14, 1322067, 2023
2023
Progressive Ataxia and Palatal Tremor Is Not Associated with IgLON5 Antibodies: Results From Two Cases
A Mastrangelo, MP Giannoccaro, V Donadio, F Ricciardiello, F Di Laudo, ...
The Cerebellum, 1-4, 2023
2023
Tracking neurodegenerative diseases in biofluids: Combining pathology and pathophysiology markers is the way
A Mastrangelo, A Mammana, P Parchi
Cell Chemical Biology 30 (11), 1340-1342, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–15